These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4196447)

  • 1. Comparative activity of sisomicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.
    Pejovic H; Cacciatore R; Valdez H; Dunbar FP; Sanders WE
    J Infect Dis; 1973 Jun; 127(6):720-2. PubMed ID: 4196447
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice.
    Sanders WE; Cacciatore R; Valdez H; Pejovic I; Dunbar FP
    J Infect Dis; 1971 Dec; 124 Suppl():S33-6. PubMed ID: 5001628
    [No Abstract]   [Full Text] [Related]  

  • 3. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. I. The antimycobacterial efficacy made in vitro and in vivo.
    Trnka L; Kuska J; Havel A
    Chemotherapia (Basel); 1964-1965; 9(3):158-67. PubMed ID: 4953657
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis.
    Sanders WE; Hartwig C; Schneider N; Cacciatore R; Valdez H
    Tubercle; 1982 Sep; 63(3):201-8. PubMed ID: 6817487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary trial of lividomycin in patients with pulmonary tuberculosis.
    Tsukamura M
    Tubercle; 1972 Mar; 53(1):43-6. PubMed ID: 5038199
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of isoniazid for the therapy of experimental infection with total INH- and SM- resistant human tuberculosis bacteria in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):14-29. PubMed ID: 4320557
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-resistant tuberculosis.
    Bonforte RJ; Gribetz I
    N Engl J Med; 1971 Apr; 284(14):795-6. PubMed ID: 4994047
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
    Pavlova MV; Skvortsova LA; Kondakova MN; Sapozhnikova NV
    Probl Tuberk Bolezn Legk; 2004; (1):24-6. PubMed ID: 15137140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI; El'shanskaia MP
    Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of drug resistance and restoration of sensitivity of Mycobacterium tuberculosis isolated from patients].
    Belogurova VP; Navrotskiĭ VV
    Antibiotiki; 1970 May; 15(5):434-7. PubMed ID: 4988018
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of tobramycin on Pseudomonas keratitis.
    Smolin G; Okumoto M; Wilson FM
    Am J Ophthalmol; 1973 Oct; 76(4):555-60. PubMed ID: 4200625
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the antituberculous activity of morphazinamide and pyrazinamide on chronic experimental tuberculosis. II. The emergence of resistance and its retardation in the course of monotherapy and combinations of antituberculous drugs.
    Havel A; Trnka L; Kuska J
    Chemotherapia (Basel); 1964-1965; 9(3):168-75. PubMed ID: 4953658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical forms of new cases of tuberculosis at Kaunas Romainiai Tuberculosis Hospital in 1998-2001].
    Naudziūnas A; Jacunskiene L; Tarūta A
    Medicina (Kaunas); 2004; 40(1):42-5. PubMed ID: 14764981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research on the ultrastructure of certain strains of Mycobacteria isolated from tuberculosis patients, with different sensitivity to isoniazid and streptomycin].
    Radanov R; Spassova N; Kalfin E
    Ann Sclavo; 1972; 14(1):103-12. PubMed ID: 4205219
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.
    Elghoul MT; Joshi RM; Rizghalla T
    Trop Geogr Med; 1989 Oct; 41(4):304-8. PubMed ID: 2517554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.